nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.09.2023 | Review

Artificial intelligence in breast cancer: application and future perspectives

verfasst von: Shuixin Yan, Jiadi Li, Weizhu Wu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 17/2023

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is one of the most common cancers and is one of the leading causes of cancer-related deaths in women worldwide. Early diagnosis and treatment are the key for a favorable prognosis. The application of artificial intelligence technology in the medical field is increasingly extensive, including image analysis, automated diagnosis, intelligent pharmaceutical system, personalized treatment and so on. AI-based breast cancer imaging, pathology and adjuvant therapy technology cannot only reduce the workload of clinicians, but also continuously improve the accuracy and sensitivity of breast cancer diagnosis and treatment. This paper reviews the application of AI in breast cancer, as well as looks ahead and poses challenges to the future development of AI for breast cancer detection and therapeutic, so as to provide ideas for future research.

Alsharif WM (2023) The utilization of artificial intelligence applications to improve breast cancer detection and prognosis. Saudi Med J 44(2):119–127. https://doi.org/10.15537/smj.2023.44.2.20220611CrossRefPubMedPubMedCentral

Araujo T, Aresta G, Castro E et al (2017) Classification of breast cancer histology image using convolutional neural networks. PLoS One 12(6):e0177544PubMedPubMedCentralCrossRef

Ayatollahi F, Shokouhi SB, Mann RM, Teuwen J (2021) Automatic breast lesion detection in ultrafast DCE-MRI using deep learning. Med Phys 48:5897–5907PubMedCrossRef

Bera K, Schalper KA, Rimm DL et al (2019) Artificial intelligence in digital pathology-new tools for diagnosis and precision oncology. Nat Rev Clin Oncol 16(11):703–715PubMedPubMedCentralCrossRef

Bickelhaupt S, Paech D, Kickingereder P et al (2017) Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography. J Magn Reson Imaging 46(2):604–616PubMedCrossRef

Bluemke DA, Moy L, Bredella MA et al (2020) Assessing radiology research on artificial intelligence: a brief guide for authors, reviewers, and readers-from the Radiology editorial board. Radiology 294(3):487–489PubMedCrossRef

Chiang TC, Huang YS, Chen RT et al (2019) Tumor detection in automated breast ultrasound using 3-D CNN and prioritized candidate aggregation. IEEE Trans Med Imaging 38(1):240–249PubMedCrossRef

Fujioka T, Katsuta L, Kubota K, Mori M, Kikuchi Y, Kato A, Oda G, Nakagawa T, Kitazume Y, Tateishi U (2020) Classification of breast masses on ultrasound shear wave elastography using convolutional neural networks. Ultrason Imaging 42(4–5):213–220PubMedCrossRef

Cruz-Roa A, Gilmore H, Basavanhally A, Feldman M, Ganesan S, Shih NNC, Tomaszewski J, González FA, Madabhushi A (2017) Accurate and reproducible invasive breast cancer detection in whole-slide images: a deep learning approach for quantifying tumor extent. Sci Rep 7:46450PubMedPubMedCentralCrossRef

Dahlblom V, Andersson I, Lång K, Tingberg A, Zackrisson S, Dustler M (2021) Artificial intelligence detection of missed cancers at digital mammography that were detected at digital breast tomosynthesis. Radiol Artif Intell 3:e200299PubMedPubMedCentralCrossRef

Deo RC (2015) Machine learning in medicine. Circulation 132(20):1920–1930PubMedPubMedCentralCrossRef

Douglass C, Goldsmith P (2023) IBM Watson health and broad institute launch major research initiative to study why cancers become drug resistant. www.broadinstitute.org/news/ibm-watson-health-and-broad-institute-launch-major-research-initiative-study-why-cancers-become. Accessed 10 Nov 2016

Ellwood MA, Ahmed M, Segler MH et al (2018) Artificial in-telligence in drug discovery. Future Med Chem 10(17):2025–2028CrossRef

Gao YT, Shu XO, Dai Q et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai breast cancer study. Int J Cancer 87(2):295PubMedCrossRef

Goldhirsch A, Winer E, Coates A et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 24:2206–2223PubMedPubMedCentralCrossRef

Greenspan H, Ginneken BV, Summers RM (2016) Guest editorial deep learning in medical imaging: overview and future promise of an exciting new technique. IEEE Trans Med Imaging 35(5):1153–1159CrossRef

Hamet P, Tremblay J (2017) Artificial intelligence in medicine. Metabolism 69S:S36–S40PubMedCrossRef

Herent P, Schmauch B, Jehanno P, Dehaene O, Saillard C, Balleyguier C et al (2019) Detection and characterization of MRI breast lesions using deep learning. Diagn Interv Imaging 100:219–225PubMedCrossRef

Hu L, Bell D, Antani S, Xue Z et al (2019) An observational study of deep learning and automated evaluation of cervical images for cancer screening. J Natl Cancer Inst 111:923–932PubMedPubMedCentralCrossRef

Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S (2017) Pathologic findings of breast lesions detected on magnetic resonance imaging. Arch Pathol Lab Med 141(11):1513–1522PubMedCrossRef

Jiang Y, Yang M, Wang S, Li X, Sun Y (2020) Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun (lond) 40(4):154–166PubMedCrossRef

Jiang Y, Edwards AV, Newstead GM (2021) Artificial intelligence applied to breast MRI for improved diagnosis. Radiology 298(1):38–46PubMedCrossRef

Jing X, Wielema M, Cornelissen LJ, van Gent M, Iwema WM, Zheng S et al (2022) Using deep learning to safely exclude lesions with only ultrafast breast MRI to shorten acquisition and reading time. Eur Radiol 32:1–10CrossRef

Jun B, Russell P, Tianyu W, Clifford Y, Sheida N (2021) Applying deep learning in digital breast tomosynthesis for automatic breast cancer detection: a review. Med Image Anal 71:102049CrossRef

Kempowsky-Hamon T, Valle C, Lacroix-Triki M et al (2015) Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer–the INNODIAG study. BMC Med Genom 8:3CrossRef

Kim W, Kim KS, Lee JE, Noh DY, Kim SW, Jung YS, Park MY, Park RW (2012) Development of novel breast cancer recurrence prediction model using support vector machine. J Breast Cancer 15(2):230–238PubMedPubMedCentralCrossRef

Kim K, Song MK, Kim EK, Yoon JH (2017) Clinical application of S-Detect to breast masses on ultrasonography: a study evaluating the diagnostic performance and agreement with a dedicated breast radiologist. Ultrasonography 36:3–9PubMedCrossRef

Klimov S, Miligy IM, Gertych A (2019) A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk. Breast Cancer Res 21(1):83PubMedPubMedCentralCrossRef

Kumar Y, Koul A, Singla R, Ijaz MF (2022) Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda. J Ambient Intell Humaniz Comput 14:1–28

Lecun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521(7553):436–444PubMedCrossRef

Lehman CD, Yala A, Schuster T et al (2019) Mammographic breast density assessment using deep learning: clinical implementation. Radiology 290(1):52–58PubMedCrossRef

Lima ZS, Ebadi MR, Amjad G, Younesi L (2019) Application of imaging technologies in breast cancer detection: a review article. Open Access Maced J Med Sci 7(5):838–848PubMedPubMedCentralCrossRef

Litjens G, Sánchez CI, Timofeeva N et al (2016a) Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci Rep 6(1):4986CrossRef

Litjens G, Sánchez CI, Timofeeva N et al (2016b) Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. Sci Rep 6:26286PubMedPubMedCentralCrossRef

Liu H, Cui G, Luo Y, Guo Y, Zhao L, Wang Y, Subasi A, Dogan S, Tuncer T (2022) Artificial intelligence-based breast cancer diagnosis using ultrasound images and grid-based deep feature generator. Int J Gen Med 15:2271–2282PubMedPubMedCentralCrossRef

Lötsch J, Sipilä R, Tasmuth T, Kringel D, Estlander AM, Meretoja T, Kalso E, Ultsch A (2018) Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy. Breast Cancer Res Treat 171(2):399–411PubMedPubMedCentralCrossRef

Luo J, Ning Z, Zhang S et al (2018) Bag of deep features for preoperative prediction of sentinel lymph node metastasis in breast cancer. Phys Med Biol 63(24):245014PubMedCrossRef

Ma M, Zhang Y, Wang X et al (2021) Automatic classification of background parenchymal reinforcement in breast MRI based on deep learning and threshold segmentation methods. Tumor Imaging 30(5):332–338

Mendelson EB (2019) Artificial intelligence in breast imaging: potentials and limitations. Am J Roentgenol 212(2):293–299CrossRef

Meng Y et al (2021) Can AI-assisted microscope facilitate breast HER2 interpretation? A Multi-Institutional Ring Study. Virchows Arch 479(3):443–449CrossRef

Meskó B, Görög M (2020) A short guide for medical professionals in the era of artificial intelligence. NPJ Digit Med 3:126PubMedPubMedCentralCrossRef

Michell M, Batohi B (2018) Role of tomosynthesis in breast imaging going forward. Clin Radiol 73(4):358–371PubMedCrossRef

Mohammed AN, Sanaa EF, Kawtar A et al (2021) Machine learning algorithms for breast cancer prediction and diagnosis. Procedia Comput Sci 191:487–492CrossRef

Ortega I, Roy P et al (2020) Deep learned tissue “fingerprints” classify breast cancers by ER/PR/Her2 status from H&E images. Sci Rep 10(1):7275PubMedPubMedCentralCrossRef

Ortiz-Rodriguez JM, Guerrero-Mendez C, Martinez-Blanco MDR et al (2018) Breast cancer detection by means of artificial neural networks. Adv Appl Artif Neural Netw 1:161–176

Park SH (2018) Artificial intelligence in medicine: beginner’s guide. J Korean Soc Radiol 78(5):301CrossRef

Paul D, Sanap G, Shenoy S et al (2021) Artificial intelligence in drug discovery and development. Drug Discov Today 26(1):80–93PubMedCrossRef

Perez SM, Binda E, Hayday AC, Barrett-Lee PJ, Eberl M (2010) Human gammadelta T cell responses in breast cancer patients during zoledronate therapy. Immunology 131:115

Petrillo A, Fusco R, Di Bernardo E et al (2022) Prediction of breast cancer histological outcome by radiomics and artificial intelligence analysis in contrast-enhanced mammography. Cancers (basel) 14(9):2132PubMedCrossRef

Riggio AI, Varley KE, Welm AL (2021) The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer 124:13–26PubMedCrossRef

Rodríguez-Ruiz A, Krupinski E, Mordang JJ, Schilling K, Heywang-Köbrunner SH, Sechopoulos I, Mann RM (2019) Detection of breast cancer with mammography: effect of an artificial intelligence support system. Radiology 290(2):305–314PubMedCrossRef

Romero-Martín S, Elías-Cabot E, Raya-Povedano JL, Gubern-Mérida A, Rodríguez-Ruiz A, Álvarez-Benito M (2022) Stand-alone use of artificial intelligence for digital mammography and digital breast tomosynthesis screening: a retrospective evaluation. Radiology 302(3):535–542PubMedCrossRef

Rosenstein BS, West CM, Bentzen SM et al (2014) Radiogenomics: radiobiology enters the era of big data and team science. Int J Radiat Oncol Biol Phys 89(4):709–713PubMedPubMedCentralCrossRef

Salim M, Wåhlin E, Dembrower K, Azavedo E, Foukakis T, Liu Y et al (2020) External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms. JAMA Oncol 6:1581–1588PubMedPubMedCentralCrossRef

Sammut SJ, Crispin-Ortuzar M, Chin SF et al (2022) Multi-omic machine learning predictor of breast cancer therapy response. Nature 601(7894):623–629PubMedCrossRef

Shen Y, Shamout FE, Oliver JR, Witowski J et al (2021) Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams. Nat Commun 12(1):5645PubMedPubMedCentralCrossRef

Somashekhar SP, Sepúlveda MJ, Puglielli S, Norden AD, Shortliffe EH, Rohit Kumar C, Rauthan A, Arun Kumar N, Patil P, Rhee K, Ramya Y (2018) Watson for oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol 29(2):418–423PubMedCrossRef

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249PubMedCrossRef

Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, Dubsky P, Baltzer P, Clauser P, Kapetas P, Morris EA, Meyer-Baese A, Pinker K (2019) Impact of machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy and survival outcomes in breast cancer patients. Investig Radiol 54(2):110–117CrossRef

Truhn D, Schrading S, Haarburger C, Schneider H, Merhof D, Kuhl C (2019) Radiomic versus convolutional neural networks analysis for classification of contrast-enhancing lesions at multiparametric breast MRI. Radiology 290:290–297PubMedCrossRef

Ullah R, Khan S, Ishtiaq I, Shahzad S, Ali H, Bilal M (2020) Cost effective and efficient screening of Alzheimer disease with Raman spectroscopy and machine learning algorithms. Photodiagn Photodyn Ther 32:101963CrossRef

Valieris R, Amaro L, Osório CABT, Bueno AP, Rosales Mitrowsky RA, Carraro DM, Nunes DN, Dias-Neto E, Silva ITD (2020) Deep learning predicts underlying features on pathology images with therapeutic relevance for breast and gastric cancer. Cancers (basel) 12(12):3687PubMedCrossRef

van de Sande D, Sharabiani M, Bluemink H et al (2021) Artificial intelligence based treatment planning of radiotherapy for locally advanced breast cancer. Phys Imaging Radiat Oncol 20:111–116PubMedPubMedCentralCrossRef

Veta M, van Diest PJ, Willems SM (2015) Assessment of algorithms for mitosis detection in breast cancer histopathology images. Med Image Anal 20(1):237–248PubMedCrossRef

Vicini S, Bortolotto C, Rengo M, Ballerini D, Bellini D, Carbone I et al (2022) A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers. Radiol Med 1(18):819–836CrossRef

Wang J, Yang X, Cai H et al (2016) Discrimination of breast cancer with microcalcifications on mammography by deep learning. Sci Rep 6(5):1–4

Witowski J, Heacock L, Reig B, Kang SK, Lewin A, Pysarenko K, Patel S, Samreen N, Rudnicki W, Luczyńska E, Popiela T, Moy L, Geras KJ (2022) Improving breast cancer diagnostics with deep learning for MRI. Sci Transl Med 14(664):eabo4802PubMedPubMedCentralCrossRef

Wu G-G, Zhou L-Q, Xu J-W, Wang J-Y, Wei Q, Deng Y-B, Cui X-W, Dietrich CF (2019) Artificial intelligence in breast ultrasound. World J Radiol 11(2):19–26PubMedPubMedCentralCrossRef

Xie N, Zhou H, Yu L, Huang S, Tian C, Li K, Jiang Y, Hu ZY, Ouyang Q (2022) Artificial intelligence scale-invariant feature transform algorithm-based system to improve the calculation accuracy of Ki-67 index in invasive breast cancer: a multicenter retrospective study. Ann Transl Med 10(19):1067PubMedPubMedCentralCrossRef

Xu F, Sepúlveda MJ, Jiang Z et al (2019) Artificial intelligence treatment decision support for complex breast cancer among oncologists with varying expertise. JCO Clin Cancer Inform 3:1–15PubMedCrossRef

Yu Y, He Z, Ouyang J, Tan Y, Chen Y, Gu Y, Mao L, Ren W, Wang J, Lin L, Wu Z, Liu J, Ou Q, Hu Q, Li A, Chen K, Li C, Lu N, Li X, Su F, Liu Q, Xie C, Yao H (2021) Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study. EBioMedicine 69:103460PubMedPubMedCentralCrossRef

Yun S, Ryu C, Rhee S et al (2017) Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis. Breast Cancer Res Treat 164(3):557–569PubMedCrossRef

Zhang Y, Chen J-H, Chang K-T, Park VY, Kim MJ, Chan S et al (2019) Automatic breast and fibroglandular tissue segmentation in breast MRI using deep learning by a fully-convolutional residual neural network U-net. Acad Radiol 26:1526–1535PubMedPubMedCentralCrossRef

Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, Mao R, Li F, Xiao Y, Wang Y, Hu Y, Yu J, Zhou J (2020) Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun 11(1):1236PubMedPubMedCentralCrossRef

Zhou J, Luo LY, Dou Q, Chen H, Chen C, Li GJ et al (2019) Weakly supervised 3D deep learning for breast cancer classification and localization of the lesions in MR images. J Magn Reson Imaging 50:1144–1151PubMedCrossRef

Zhou J, Zhang Y, Chang KT, Lee KE, Wang O, Li J et al (2020) Diagnosis of benign and malignant breast lesions on DCE-MRI by using radiomics and deep learning with consideration of peritumor tissue. J Magn Reson Imaging 51:798–809PubMedCrossRef

Titel: Artificial intelligence in breast cancer: application and future perspectives
verfasst von: Shuixin Yan
Jiadi Li
Weizhu Wu
Publikationsdatum: 01.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 17/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-023-05337-2

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Artificial intelligence in breast cancer: application and future perspectives

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 17/2023

A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma

Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes

Precise pattern of lymphatic spread of esophageal squamous cell carcinoma: results of 1074 patients with N1 disease

Role of extracellular vesicle in human papillomavirus-associated cervical cancer

STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer

BTB protein family and human breast cancer: signaling pathways and clinical progress

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie